Search
Coagulation Factor IX (Recombinant)
go.drugbank.com/drugs/DB00100ApprovedIt has a primary amino acid sequence that is identical to the Ala148 allelic form of human factor IX, and has structural and functional characteristics similar to those of endogenous factor IX. … Recombinant Coagulation Factor IX is a purified Factor IX glycoprotein produced by recombinant DNA technology.
Products: BENEFIX 500 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCU, 1 ADET, BENEFIX 1000 IU IV ENJEKSIYONLUK COZELTI ICIN TOZ VE COZUCUZopiclone
go.drugbank.com/drugs/DB01198ApprovedInvestigationalIn addition to zopiclone's benzodiazepine pharmacological properties it also has some barbiturate-like properties.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C8 SubstratesSynonyms: 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylateFavipiravir
go.drugbank.com/drugs/DB12466ApprovedInvestigationalinfluenza strains that are resistant to neuramidase inhibitors. … Discovered by Toyama Chemical Co., Ltd. in Japan, favipiravir is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza.
Categories: Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2E1 InhibitorsProducts: POLİCOVİR 200 MG FİLM KAPLI TABLET, 40 ADET, KOVİPİR 200 MG FİLM KAPLI TABLET, 40 ADETImiquimod
go.drugbank.com/drugs/DB00724ApprovedInvestigationalImiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. … Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment.
International brands: Nan BoMixtures: Imiquimod 5% / Salicylic Acid 30% / Tretinoin 0.1%, Imiquimod 5% / Niacinamide 4%Mifepristone
go.drugbank.com/drugs/DB00834ApprovedInvestigationalAs a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary cushing syndrome. … Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InducersProducts: MIFEPRISTONA 200 MG, MIFEPRISTONE 200 MGAgomelatine
go.drugbank.com/drugs/DB06594ApprovedInvestigationalAgomelatine was developed in Europe by Servier Laboratories Ltd. and submitted to the European Medicines Agency (EMA) in 2005. … Agomelatine is structurally closely related to melatonin.
Categories: Serotonin 5-HT2 Receptor Antagonists, Serotonin 5-HT2C Receptor AntagonistsProducts: VALDOXAN 25 MG, VALDOXAN® 25 MGcDNA FLJ60754, moderately similar to Survival motor neuron protein
go.drugbank.com/bio_entities/BE0009143TargetHumansPolypeptides: cDNA FLJ60754, moderately similar to Survival motor neuron proteinSynonyms: cDNA FLJ60754, moderately similar to Survival motor neuron proteinTravoprost
go.drugbank.com/drugs/DB00287ApprovedInvestigationalIt is used to decrease intraocular pressure in open-angle glaucoma and ocular hypertension.
Mixtures: DUOTRAV 40 MCG/ML+5 MG/ML GÖZ DAMLASI, ÇÖZELTİ, 2.5 ML, Jokath 40 Mikrogramm/ml + 5 mg/ml Augentropfen, LösungSynonyms: OTX-TP, isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(α,α,α-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoatePazopanib
go.drugbank.com/drugs/DB06589ApprovedInvestigationalIt is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesProducts: VOPAZZİ 400 MG FİLM KAPLI TABLET, 60 ADET, VOTRIENT 400 MG FİLM KAPLI TABLET, 60 ADETCarglumic acid
go.drugbank.com/drugs/DB06775ApprovedInvestigationalCarglumic acid was approved by the U.S. Food and Drug Administration (FDA) on 18 March 2010.
Products: UCEDANE 200 MG DAĞILABİLİR TABLET, 60 ADET, PERLUGA 200 MG DAĞILABİLİR TABLET, 60 ADET